🇺🇸 Viking Therapeutics, Inc.
Forum topic · VKTX · Company page: financials, ownership and filings
Join the discussion on Viking Therapeutics, Inc.
Loading…
Results announced on 28 October 2026
Viking Therapeutics, Inc. announced results on 28 October 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $183 million.
Mutual funds: 219 funds hold $1.0 billion
219 mutual funds in 2 countries hold shares of Viking Therapeutics, Inc. worth $1.0 billion, about 22.3% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 95 funds added shares and 70 sold; on balance they bought $54 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.